## **Core Concept**
The question tests knowledge of antimicrobials with specific activity against *Pseudomonas aeruginosa*, a Gram-negative bacterium known for its resistance to many antibiotics. Antipseudomonal antibiotics are crucial in treating infections caused by this pathogen, particularly in immunocompromised patients or those with cystic fibrosis.

## **Why the Correct Answer is Right**
The correct answer, , is effective against *Pseudomonas aeruginosa* due to its mechanism of action. It belongs to the class of antipseudomonal penicillins (or ureidopenicillins) and works by inhibiting bacterial cell wall synthesis. This class of antibiotics is known for its broad spectrum of activity, including efficacy against *Pseudomonas* species.

## **Why Each Wrong Option is Incorrect**
* **Option A:** lacks significant activity against *Pseudomonas aeruginosa*. It is a first-generation cephalosporin with a narrower spectrum that primarily targets Gram-positive bacteria and some Gram-negative bacteria but not *Pseudomonas*.
* **Option B:** does not have reliable activity against *Pseudomonas aeruginosa*. It is often used for infections caused by susceptible Gram-positive and Gram-negative bacteria but is not considered an antipseudomonal agent.
* **Option D:** is not known for its antipseudomonal activity. While it has a broad spectrum of activity, its efficacy against *Pseudomonas aeruginosa* is limited or variable, making it not the best choice for infections caused by this organism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that when treating infections suspected or confirmed to be caused by *Pseudomonas aeruginosa*, selecting an antibiotic with known antipseudomonal activity is critical. is one such option, often used in combination with other antibiotics for synergistic effects, especially in severe infections.

## **Correct Answer:** .